World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
42648
World Ranking
11115
National Ranking
5720

Research.com Recognitions

  • 2018 - Member of the National Academy of Medicine (NAM)

Overview

Kunle Odunsi is affiliated with the Roswell Park Cancer Institute in the United States. Their research spans multiple fields, primarily focusing on medicine, immunology and microbiology, and biochemistry, genetics, and molecular biology. Within these domains, their work covers subfields such as immunology, oncology, molecular biology, reproductive medicine, and genetics.

The scientist's research topics include cancer immunotherapy and biomarkers, immunotherapy and immune responses, CAR-T cell therapy research, immune cell function and interaction, ovarian cancer diagnosis and treatment, immune cells in cancer, and RNA modifications and cancer.

Odunsi has authored papers published in various venues, with frequent contributions to Gynecologic Oncology, bioRxiv (Cold Spring Harbor Laboratory), the Journal for ImmunoTherapy of Cancer, Cancer Research, and the Journal of Clinical Oncology.

Notable recent publications include:

  • Global DNA hypomethylation in epithelial ovarian cancer: passive demethylation and association with genomic instability, 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • Efficacy and Safety of Pembrolizumab in Combination With Bevacizumab and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Ovarian Cancer, 2020, JAMA Oncology
  • T-cell CX3CR1 expression as a dynamic blood-based biomarker of response to immune checkpoint inhibitors, 2021, Nature Communications
  • Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial, 2023, Nature Medicine
  • Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability, 2020, Cancers

Frequent co-authors in their research include Emese Zsíros, Junko Matsuzaki, Takemasa Tsuji, Brahm H. Segal, and Sebastiano Battaglia.

Odunsi was recognized as a member of the National Academy of Medicine (NAM) in 2018.

Best Publications

  • Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

    Julie R. Brahmer;Scott S. Tykodi;Scott S. Tykodi;Laura Q.M. Chow;Wen Jen Hwu

  • Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer

    Eiichi Sato;Sara H. Olson;Jiyoung Ahn;Brian Bundy

  • Tumor-infiltrating NY-ESO-1–specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

    Junko Matsuzaki;Sacha Gnjatic;Paulette Mhawech-Fauceglia;Amy Beck

  • Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk

    Ganna Chornokur;Hui-Yi Lin;Jonathan P. Tyrer;Kate Lawrenson

  • Gene expression markers of Tumor Infiltrating Leukocytes

    Patrick Danaher;Sarah Warren;Lucas Dennis;Leonard D’Amico

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek

  • The mTOR Kinase Determines Effector versus Memory CD8+ T Cell Fate by Regulating the Expression of Transcription Factors T-bet and Eomesodermin

    Rajesh R. Rao;Qingsheng Li;Kunle Odunsi;Protul A. Shrikant

  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

    Stig E. Bojesen;Stig E. Bojesen;Karen A. Pooley;Sharon E. Johnatty;Jonathan Beesley

  • Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

    Timothy R. Rebbeck;Nandita Mitra;Fei Wan;Olga M. Sinilnikova

  • PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment.

    Nataša Obermajer;Ravikumar Muthuswamy;Kunle O. Odunsi;Robert P. Edwards

  • Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study

    Weiva Sieh;Martin Köbel;Teri A Longacre;David D Bowtell;David D Bowtell

  • Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

    Susan J. Ramus;Honglin Song;Ed Dicks;Jonathan P. Tyrer

  • Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

    Catherine M Phelan;Karoline B Kuchenbaecker;Karoline B Kuchenbaecker;Jonathan P Tyrer;Siddhartha P Kar

  • Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

    M. E. Mikucki;D. T. Fisher;J. Matsuzaki;J. J. Skitzki

  • Detection of epithelial ovarian cancer using 1H‐NMR‐based metabonomics

    Kunle Odunsi;Robert M. Wollman;Christine B. Ambrosone;Alan Hutson

  • GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

    Paul D.P. Pharoah;Ya Yu Tsai;Susan J. Ramus;Catherine M. Phelan

  • A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.

    Jie Shen;Christine B. Ambrosone;Richard A. DiCioccio;Kunle Odunsi

  • Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer

    Yoshihiro Miyahara;Kunle Odunsi;Wenhao Chen;Guangyong Peng

  • Ovarian Cancer Spheroid Cells with Stem Cell-Like Properties Contribute to Tumor Generation, Metastasis and Chemotherapy Resistance through Hypoxia-Resistant Metabolism

    Jianqun Liao;Feng Qian;Nana Tchabo;Paulette Mhawech-Fauceglia

  • Immunotherapy in ovarian cancer.

    K Odunsi

Frequent Co-Authors

Susan J. Ramus
Susan J. Ramus University of New South Wales
Graham G. Giles
Graham G. Giles University of Melbourne
Ian G. Campbell
Ian G. Campbell Peter MacCallum Cancer Centre
Ellen L. Goode
Ellen L. Goode Mayo Clinic
Jenny Chang-Claude
Jenny Chang-Claude German Cancer Research Center
Beth Y. Karlan
Beth Y. Karlan University of California, Los Angeles
Jennifer A. Doherty
Jennifer A. Doherty University of Utah
Brahm H. Segal
Brahm H. Segal Roswell Park Cancer Institute
Joellen M. Schildkraut
Joellen M. Schildkraut University of Virginia
Roberta B. Ness
Roberta B. Ness The University of Texas Health Science Center at Houston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in Medicine but aren’t sure medical school is the right path, there are several related healthcare degrees you can pursue online. These programs offer flexibility and affordability while opening doors to rewarding roles in the healthcare industry.

For those interested in pharmacy, options such as pharmacy school online accredited programs make it possible to earn a high-level qualification from home. Health informatics is another fast-growing field; choosing from respected healthcare informatics degree programs can lead to roles managing health data and technology for hospitals and clinics.

If you’re seeking a faster route to entering the workforce, a low cost medical coding and billing online program can quickly equip you with essential skills for supporting healthcare administration. Prospective nurses might consider the cheapest online acute care nurse practitioner programs to advance their clinical expertise and career prospects.

Exploring these online pathways allows students to tailor their education to their career goals while benefiting from flexible schedules and a wide range of specialties.

Best Scientists Citing Kunle Odunsi

Trending Scientists

Recently Published Articles